Regular aspirin use and breast cancer risk in US black women

Cancer Causes and Control

Volumn 22, Issue 11, 2011, Pages 1553-1561

  Bosco, Jaclyn L F ^a   Palmer, Julie R ^b,c   Boggs, Deborah A ^c   Hatch, Elizabeth E ^b   Rosenberg, Lynn ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Aspirin; Breast cancer; Epidemiology; Incidence; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG USE; EDUCATION; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SMOKING;

ACETAMINOPHEN; ADULT; AFRICAN AMERICANS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 82955232416     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9832-6     Document Type: Article

References (51)

1. Rosenberg L, Louik C, Shapiro S (1998) Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer 82:2326-2333 (Pubitemid 28283438)
2. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355-358
3. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252-266 (Pubitemid 34196319)
4. Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 22:303-309 (Pubitemid 34205168)
5. Bosetti C, Gallus S, La Vecchia C (2006) Aspirin and cancer risk: An updated quantitative review to 2005. Cancer Causes Control 17:871-888 (Pubitemid 44081706)
6. DuBois RN (2004) Aspirin and breast cancer prevention. JAMA 291:2488-2489
7. The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616
8. Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455-460 (Pubitemid 28160637)
9. Diaz-Cruz ES, Shapiro CL, Brueggemeier RW (2005) Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab 90:2563-2570 (Pubitemid 40686292)
10. Howe LR, Lippman SM (2008) Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst 100:1420-1423
11. Harris RE, Namboodiri KK, Stellman SD, Wynder EL (1995) Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med 24:119-120
12. Harris RE, Chlebowski RT, Jackson RD et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63: 6096-6101 (Pubitemid 37187516)
13. Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomark Prev 11: 1586-1591 (Pubitemid 36020011)
14. Ready A, Velicer C, McTiernan A, White E (2008) NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat 109:533-543 (Pubitemid 351692052)
15. Jacobs EJ, Thun MJ, Connell CJ et al (2005) Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large US cohort. Cancer Epidemiol Biomark Prev 14: 261-264 (Pubitemid 40165311)
16. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88:988-993 (Pubitemid 26239387)
17. Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE (2009) Use of aspirin, other nonsteroidal antiinflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med 169:115-121
18. Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97:805-812 (Pubitemid 40909123)
19. Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN (2007) Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 166:1150-1158 (Pubitemid 350022753)
20. Gierach G, Lacey J, Schatzkin A et al (2008) Nonsteroidal antiinflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 10:R38
21. Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: The Women's Health Study: A randomized controlled trial. JAMA 294:47-55 (Pubitemid 41002838)
22. Zhang SM, Cook NR, Manson JE, Lee I-M, Buring JE (2008) Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. Br J Cancer 98:989-991 (Pubitemid 351341601)
23. Moorman P, Grubber J, Millikan R, Newman B (2003) Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14:915-922 (Pubitemid 38091212)
24. Palmer JR, Rao SR, Adams-Campbell LL, Rosenberg L (2001) Height and breast cancer risk: results from the Black Women's Health Study (United States). Cancer Causes Control 12:343-348 (Pubitemid 32553627)
25. Kelley KE, Kelley TP, Kaufman DW, Mitchell AA (2003) The Slone Drug Dictionary: A research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 12(S1):S168-S198
26. Stephenson GD, Rose DP (2003) Breast cancer and obesity: An update. Nutr Cancer 45:1-16 (Pubitemid 36736886)
27. Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: A systematic review. Epidemiol 18:137-157 (Pubitemid 46005918)
28. Band PR, Le ND, Fang R, Deschamps M (2002) Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044-1049
29. Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149-156 (Pubitemid 43159501)
30. Kelsey JL (1993) Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15:256-263
31. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36-47 (Pubitemid 23269069)
32. Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7-16 (Pubitemid 23269067)
33. Cox DR (1972) Regression models and life-tables. J R Stat Soc Ser B Methodol 34:187-220
34. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York
35. Coogan PF, Rao SR, Rosenberg L et al (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 29:72-76 (Pubitemid 29406779)
36. Brasky TM, Bonner MR, Moysich KB et al (2010) Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 21:1503-1512
37. Pedersen AT, Ottesen B (2003) Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trial-time out for hormone replacement therapy studies? Hum Reprod 18:2241-2244 (Pubitemid 37427797)
38. Garcia Rodriguez LA, Gonzalez-Perez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91:525-529 (Pubitemid 39093573)
39. Cronin-Fenton D, Pedersen L, Lash T, Friis S, Baron J, Sørensen HT (2010) Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res 12:R15
40. Harris R, Beebe-Donk J, Alshafie G (2006) Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6:27
41. Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M (2005) Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5:159
42. Terry MB, Gammon MD, Zhang FF et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433-2440 (Pubitemid 38669186)
43. Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ (2007) Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer 121:211-215 (Pubitemid 46753870)
44. Friis S, Thomassen L, Sørensen HT et al (2008) Nonsteroidal anti-inflammatory drug use and breast cancer risk: A Danish cohort study. Euro J Cancer Prev 17:88-96 (Pubitemid 351301619)
45. Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE (2010) Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomark Prev 19:1033-1041
46. Graham GG, Scott KF (2005) Mechanism of action of paracetamol. Am J Therap 12:46-55 (Pubitemid 40516046)
47. Anderson BJ (2008) Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth 18:915-921
48. Aronoff DM, Oates JA, Boutaud O (2006) New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Therapeutics 79:9-19 (Pubitemid 43069574)
49. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327 (Pubitemid 23097110)
50. Garcia Rodriguez LA, Gonzalez-Perez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 91:525-529 (Pubitemid 39093573)
51. Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiol 5:135-146